Literature DB >> 6496531

Adrenomedullary response to maximal stress in humans.

J Wortsman, S Frank, P E Cryer.   

Abstract

The most important neuroendocrine response to stress is an increase in plasma epinephrine concentration. To investigate the clinical significance of this response, plasma catecholamine levels were measured (single-isotope derivative assay) in chronic stress (severe illness; n = 22) and acute maximal stress (cardiac arrest; n = 23). The results were then compared with the values from 60 normal resting subjects: epinephrine (mean +/- SEM) 0.034 +/- 0.002 ng/ml; norepinephrine 0.228 +/- 0.01 ng/ml. Chronic stress (intensive care unit patients) was associated with a fourfold elevation of epinephrine concentration (0.14 +/- 0.06 ng/ml; range 0.01 to 1.37; p less than 0.01 versus normal control subjects). Acute maximal stress (resuscitation following cardiac arrest) resulted in a greater than 300-fold increase in the plasma epinephrine level (10.3 +/- 2.9 ng/ml; range 0.36 to 35.9; n = 15; p less than 0.01). Peak plasma epinephrine levels in successfully resuscitated patients (n = 6) ranged from 0.36 to 273 ng/ml (three patients had received epinephrine therapy). The plasma norepinephrine level was increased twofold in intensive care unit patients (0.52 +/- 0.06 ng/ml; p less than 0.01) and 32-fold after cardiac arrest (7.37 +/- 1.8 ng/ml; p less than 0.01). During resuscitation, the correlation between the simultaneous epinephrine and norepinephrine levels was highly significant: r = 0.76; p less than 0.01. It is concluded that (1) chronic, severe stress produces only moderate elevations of plasma epinephrine levels (up to 1.37 ng/ml), whereas acute stress produces marked increases of plasma epinephrine that may reach the extraordinarily high level of 35.9 ng/ml, (2) the potential toxicity from the adrenomedullary response to acute stress is further exacerbated by the parallel release of norepinephrine, and (3) under close medical monitoring, it is possible to survive with plasma epinephrine concentrations as high as 273 ng/ml.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6496531     DOI: 10.1016/0002-9343(84)90512-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  27 in total

Review 1.  Neuroendocrine markers of stress.

Authors:  K M Hargreaves
Journal:  Anesth Prog       Date:  1990 Mar-Jun

Review 2.  Effects of catecholamines on secretion of adrenocorticotrophic hormone (ACTH) in man.

Authors:  S Al-Damluji; L H Rees
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

3.  Vasostatin-I, a chromogranin A-derived peptide, in non-selected critically ill patients: distribution, kinetics, and prognostic significance.

Authors:  Francis Schneider; Charlotte Bach; Hélène Chung; Luca Crippa; Thomas Lavaux; Pierre-Edouard Bollaert; Michel Wolff; Angelo Corti; Anne Launoy; Xavier Delabranche; Thierry Lavigne; Nicolas Meyer; Patrick Garnero; Marie-Hélène Metz-Boutigue
Journal:  Intensive Care Med       Date:  2012-06-16       Impact factor: 17.440

4.  Adrenal venous catecholamine concentrations in patients with adrenal masses other than pheochromocytoma.

Authors:  Yasutaka Baba; Masayuki Nakajo; Sadao Hayashi
Journal:  Endocrine       Date:  2012-09-13       Impact factor: 3.633

5.  Release of endogenous vasopressors during and after cardiopulmonary resuscitation.

Authors:  K H Lindner; T Haak; A Keller; U Bothner; K G Lurie
Journal:  Heart       Date:  1996-02       Impact factor: 5.994

6.  Pattern of elevation of urine catecholamines in intracerebral haemorrhage.

Authors:  G F Hamann; M Strittmatter; K H Hoffmann; G Holzer; M Stoll; T Keshevar; R Moili; K Wein; K Schimrigk
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 7.  Adrenaline, cardiac arrest, and evidence based medicine.

Authors:  T H Rainer; C E Robertson
Journal:  J Accid Emerg Med       Date:  1996-07

8.  Critically low hormone and catecholamine concentrations in the primed extracorporeal life support circuit.

Authors:  Michael S D Agus; Tom Jaksic
Journal:  ASAIO J       Date:  2004 Jan-Feb       Impact factor: 2.872

9.  Hyperthermia following cardiopulmonary resuscitation.

Authors:  M Takino; Y Okada
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

10.  β2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1.

Authors:  Sazzad Hassan; Ashok Pullikuth; Kyle C Nelson; Anabel Flores; Yelena Karpova; Daniele Baiz; Sinan Zhu; Guangchao Sui; Yue Huang; Young A Choi; Ralph D'Agostino; Ashok Hemal; Urs von Holzen; Waldemar Debinski; George Kulik
Journal:  Mol Cancer Res       Date:  2020-09-14       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.